Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC

NCT00173862 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Transitional Cell Carcinoma

Interventions

DRUG: Gemcitabine, Ifosfamide

Sponsor

National Taiwan University Hospital